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Treatment of finisher pigs with dietary ractopamine (RAC; Paylean", Elanco Animal Health, NSW) improves 
daily gain and feed efficiency commensurate with increased protein deposition in finishing pigs (Dunshea et al., 
1993). However, effects of RAC on P2 fat deposition are equivocal. Dunshea et al. (1993) found no change in gilts 
and barrows, whilst a trend towards reduced P2 depth was observed in boars fed dietary RAC. Exogenous porcine 
somatotropin (pST; Reporcin", OzBioPharm Pty Ltd, Victoria) improves daily gain and feed efficiency and increases 
the ratio oflean to fat in carcases of boars, gilts and barrows (Campbell et al., 1989). As both technologies are applied 
at the end of the finishing phase, it is of interest to determine whether a combination of RAC and pST has additive 
effects on pig performance. 
This study involved 48 individually penned pigs in a 2x3 factorial design with 2 sexes (gilts, boars) and 3 RAC 
dose regimes (0 ppm, 5 ppm, and 5 ppm) for 28 d, respectively, plus daily pST (5mg/ml) injections for the last 14 d 
(RAC+). All diets were formulated to contain 13.9 MJ digestible energy (DE)/kg and 0.62 g available lysine/MJ DE. 
Pigs were weighed at -7, 0, 7, 14, 21 and 28 d and voluntary feed intake (VFI) determined at d 7, 14, 21 and 28. 
Backfat at the P2 site was determined using ultrasonics at d 0, 14 and 28. Body composition was determined using dual 
energy X-ray absorptiometry (DXA) at d -1, 15 and 29 of treatment. Data were analysed by analysis of variance. 
Table 1. Effect of sex and dietary ractopamine (RAC) for 28 d without porcine somatotropin (pST) and with daily pST 
(RAC+) over the last 14 d of treatment on growth performance and tissue deposition. 
Sex (S) ... Gilt Boar P-Value 
Treatment (T) ... Control RAC RAC+ Control RAC RAC+ SED T s TxS 
ADG dO- 14 (kg/d) 1.30 1.36 1.49 1.50 O.D78 0.550 0.005 0.650 
ADG d15- 28 (kg/d) 0.91 1.08 1.15 1.30 1.20 1.25 0.081 0.260 <0.001 0.025 
FCR dO- 14 (kg/d) 2.34 2.29 2.15 2.13 0.101 0.640 0.017 0.800 
FCR d15- 28 (kg/d) 3.10 2.88 2.17 2.87 2.66 2.43 0.299 0.008 0.710 0.420 
Lean dO- 14 (kg/d) 0.84 0.94 1.15 1.14 0.065 0.330 <0.001 0.230 
Lean d15- 29 (kg/d) 0.64 0.81 0.93 0.93 0.90 1.13 0.070 <0.001 <0.001 0.170 
Fat dO- 14 (kg/d) 0.33 0.36 0.35 0.33 0.026 0.710 0.360 0.200 
Fat d15- 29 (kg/d) 0.28 0.32 0.20 0.33 0.32 0.21 0.033 <0.001 0.280 0.740 
LlP21 dO -14 (mm) 1.75 1.44 2.0 1.9 0.46 0.227 0.504 0.770 
flP21 d14 -28 (mm) 1.75 1.69 0.69 2.3 1.6 0.8 0.42 <0.001 0.548 0.558 
1L1P2 calculated by difference between dO and 14 or d14 and 28; ADG, average daily gain; FCR, feed conversion ratio; SED, standard error of difference. 
In the final two weeks RAC and RAC+ increased average daily gain (ADG; P<0.05) and lean tissue deposition 
(P<0.001) by 0.17 and 0.29 kg/d respectively in gilts and RAC+ treatment increased lean tissue deposition in boars 
by 0.9 kg/d (Table 1). In the final two weeks RAC reduced change in P2 (l1P2) in boars (P<0.05) but not fat mass, 
whereas the RAC+ treatment reduced L'1P2 (P<0.001) and fat tissue deposition (P<0.001) for both sexes. Only the 
RAC+ treatment reduced feed conversion ratio (FCR). This study demonstrates that RAC treatment alone alters lean 
tissue deposition in gilts and confirms that RAC treatment reduces l1P2 in boars, whereas RAC+ further improves lean 
and fat tissue deposition, L'1P2, and enhances FCR in both sexes. 
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